Noninvasive time and frequency predictors of long-standing atrial fibrillation early recurrence after electrical cardioversion

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 10, 2011, Pages 1241-1250

  Alcaraz, Raúl ^a   Hornero, Fernando ^b   Rieta, José J ^c  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

atrial remodeling; cardioversion; electrocardiographic signal processing; fibrillatory wave power; long standing atrial fibrillation; sample entropy

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVERSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTRICAL ATRIAL ACTIVITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RELAPSE;

AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHRONIC DISEASE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; TREATMENT OUTCOME;

EID: 80054768827     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03125.x     Document Type: Article

References (64)

1. Gall NP, Murgatroyd FD,. Electrical cardioversion for AF-the state of the art. Pacing Clin Electrophysiol 2007; 30: 554-567. (Pubitemid 46596136)
2. Alt E, Ammer R, Schmitt C, Evans F, Lehmann G, Pasquantonio J, Schmig A,. A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J 1997; 18: 1796-1804. (Pubitemid 27477931)
3. Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H,. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 2006; 108: 346-353. (Pubitemid 43339801)
4. Paraskevaidis IA, Dodouras T, Tsiapras D, Kremastinos DT,. Prediction of successful cardioversion and maintenance of sinus rhythm in patients with lone atrial fibrillation. Chest 2005; 127: 488-494. (Pubitemid 40229307)
5. Ricard P, Lévy S, Trigano J, Paganelli F, Daoud E, Man KC, Strickberger SA, et al,. Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation. Am J Cardiol 1997; 79: 815-816. (Pubitemid 27152348)
6. Tieleman RG, Gelder ICV, Crijns HJ, Kam PJD, Berg MPVD, Haaksma J, Woude HJVD, et al,. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998; 31: 167-173. (Pubitemid 28064738)
7. Lundström T, Rydén L,. Chronic atrial fibrillation. Long-term results of direct current conversion. Acta Med Scand 1988; 223: 53-59. (Pubitemid 18031560)
8. Brodsky MA, Allen BJ, Capparelli EV, Luckett CR, Morton R, Henry WL,. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol 1989; 63: 1065-1068. (Pubitemid 19117506)
9. Alt E, Ammer R, Lehmann G, Pütter K, Ayers GM, Pasquantonio J, Schömig A,. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. Am Heart J 1997; 134: 419-425. (Pubitemid 27431245)
10. Dittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH,. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989; 63: 193-197.
11. Vikman S, Mkikallio TH, Yli-Myry S, Nurmi M, Airaksinen KEJ, Huikuri HV,. Heart rate variability and recurrence of atrial fibrillation after electrical cardioversion. Ann Med 2003; 35: 36-42. (Pubitemid 36356872)
12. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI,. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991; 68: 41-46.
13. Dotsinsky I, Stoyanov T,. Optimization of bi-directional digital filtering for drift suppression in electrocardiogram signals. J Med Eng Technol 2004; 28: 178-180. (Pubitemid 38901556)
14. Martens SMM, Mischi M, Oei SG, Bergmans JWM,. An improved adaptive power line interference canceller for electrocardiography. IEEE Trans Biomed Eng 2006; 53: 2220-2231. (Pubitemid 44629860)
15. Pan J, Tompkins WJ,. A real-time QRS detection algorithm. IEEE Trans Biomed Eng 1985; 32: 230-236. (Pubitemid 15148852)
16. Alcaraz R, Rieta JJ,. Adaptive singular value cancelation of ventricular activity in single-lead atrial fibrillation electrocardiograms. Physiol Meas 2008; 29: 1351-1369.
17. Alcaraz R, Rieta JJ,. Time and frequency recurrence analysis of persistent atrial fibrillation after electrical cardioversion. Physiol Meas 2009; 30: 479-489.
18. Proakis JG, Manolakis DG,. Digital signal processing. Principles, Algorithms and Applications. 3rd edition. Upper Saddle River, NJ, Prentice-Hall, 1996.
19. Xi Q, Sahakian AV, Frohlich TG, Ng J, Swiryn S,. Relationship between pattern of occurrence of atrial fibrillation and surface electrocardiographic fibrillatory wave characteristics. Heart Rhythm 2004; 1: 656-663. (Pubitemid 40028770)
20. Richman JS, Moorman JR,. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol 2000; 278: H2039-H2049. (Pubitemid 30439218)
21. Alcaraz R, Rieta JJ,. Non-invasive organization variation assessment in the onset and termination of paroxysmal atrial fibrillation. Comput Methods Programs Biomed 2009; 93: 148-154.
22. Alcaraz R, Rieta JJ,. Sample entropy of the main atrial wave predicts spontaneous termination of paroxysmal atrial fibrillation. Med Eng Phys 2009; 31: 917-922.
23. Alcaraz R, Rieta JJ,. A non-invasive method to predict electrical cardioversion outcome of persistent atrial fibrillation. Med Biol Eng Comput 2008; 46: 625-635.
24. Alcaraz R, Rieta JJ,. A review on sample entropy applications for the non-invasive analysis of atrial fibrillation electrocardiograms. Biomed Signal Process Control 2010; 5: 1-14.
25. Bollmann A, Husser D, Stridh M, Srnmo L, Majic M, Klein HU, Olsson SB,. Frequency measures obtained from the surface electrocardiogram in atrial fibrillation research and clinical decision-making. J Cardiovasc Electrophysiol 2003; 14 (Suppl 10): S154-S161. (Pubitemid 37392997)
26. Holm M, Pehrson S, Ingemansson M, Srnmo L, Johansson R, Sandhall L, Sunemark M, et al,. Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: Introducing, validating and illustrating a new ECG method. Cardiovasc Res 1998; 38: 69-81. (Pubitemid 28275616)
27. Alcaraz R, Rieta JJ,. Wavelet bidomain sample entropy analysis to predict spontaneous termination of atrial fibrillation. Physiol Meas 2008; 29: 65-80.
28. Rieta JJ, Castells F, Sánchez C, Zarzoso V, Millet J,. Atrial activity extraction for atrial fibrillation analysis using blind source separation. IEEE Trans Biomed Eng 2004; 51: 1176-1186. (Pubitemid 38796447)
29. Capucci A, Biffi M, Boriani G, Ravelli F, Nollo G, Sabbatani P, Orsi C, et al,. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation 1995; 92: 1193-1202.
30. Chiarugi F, Varanini M, Cantini F, Conforti F, Vrouchos G,. Noninvasive ECG as a tool for predicting termination of paroxysmal atrial fibrillation. IEEE Trans Biomed Eng 2007; 54: 1399-1406. (Pubitemid 47076249)
31. Kumagai K, Akimitsu S, Kawahira K, Kawanami F, Yamanouchi Y, Hiroki T, Arakawa K,. Electrophysiological properties in chronic lone atrial fibrillation. Circulation 1991; 84: 1662-1668.
32. Anter E, Callans DJ, Wyse DG,. Pharmacological and electrical conversion of atrial fibrillation to sinus rhythm is worth the effort. Circulation 2009; 120: 1436-1443.
33. Marchese P, Bursi F, Delle Donne G, Malavasi V, Casali E, Barbieri A, Melandri F, et al., Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion. Eur J Echocardiogr 2011; 12: 214-221.
34. Kosior DA, Szulc M, Opolski G, Torbicki A, Rabczenko D,. Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: Is the treatment's success predictable Heart Vessels 2006; 21: 375-381.
35. Yamada T, Fukunami M, Ohmori M, Iwakura K, Kumagai K, Kondoh N, Tsujimura E, et al,. New approach to the estimation of the extent of myocardial fibrosis in patients with dilated cardiomyopathy: Use of signal-averaged electrocardiography. Am Heart J 1993; 126 (3 Pt 1): 626-631. (Pubitemid 23274295)
36. Nault I, Lellouche N, Matsuo S, Knecht S, Wright M, Lim KT, Sacher F, et al,. Clinical value of fibrillatory wave amplitude on surface ECG in patients with persistent atrial fibrillation. J Interv Card Electrophysiol 2009; 26: 11-19.
37. Morillo CA, Klein GJ, Jones DL, Guiraudon CM,. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995; 91: 1588-1595.
38. Chang CJ, Lin YJ, Higa S, Chang SL, Lo LW, Tuan TC, Hu YF, et al,. The disparities in the electrogram voltage measurement during atrial fibrillation and sinus rhythm. J Cardiovasc Electrophysiol 2010; 21: 393-398.
39. Holmqvist F, Stridh M, Waktare JEP, Sörnmo L, Roijer A, Meurling CJ,. Indices of electrical and contractile remodeling during atrial fibrillation in man. Pacing Clin Electrophysiol 2006; 29: 512-519.
40. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA,. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-1968.
41. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S,. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 1997; 81: 512-525. (Pubitemid 27432738)
42. Ravelli F, Masé M, Greco MD, Faes L, Disertori M,. Deterioration of organization in the first minutes of atrial fibrillation: A beat-to-beat analysis of cycle length and wave similarity. J Cardiovasc Electrophysiol 2007; 18: 60-65. (Pubitemid 44952745)
43. Holmqvist F, Stridh M, Waktare JEP, Srnmo L, Olsson SB, Meurling CJ,. Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation. Eur Heart J 2006; 27 (18): 2201-2207. (Pubitemid 44412835)
44. Climent VE, Marin F, Mainar L, Gomez-Aldaravi R, Martinez JG, Chorro FJ, Roman P, et al,. Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2004; 27 (3): 368-372. (Pubitemid 38352519)
45. Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF,. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur Heart J 2000; 21: 66-73. (Pubitemid 30042671)
46. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, et al,. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354. (Pubitemid 44252297)
47. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, et al,. Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators. N Engl J Med 2000; 342: 913-920. (Pubitemid 30177051)
48. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, Cobbe S, et al,. European Heart Survey Investigators. Atrial fibrillation management: A prospective survey in ESC member countries: The euro heart survey on atrial fibrillation. Eur Heart J 2005; 26: 2422-2434. (Pubitemid 41552972)
49. Bollmann A, Mende M, Neugebauer A, Pfeiffer D,. Atrial fibrillatory frequency predicts atrial defibrillation threshold and early arrhythmia recurrence in patients undergoing internal cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol 2002; 25: 1179-1184.
50. Bollmann A, Husser D, Steinert R, Stridh M, Srnmo L, Olsson SB, Polywka D, et al,. Echocardiographic and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion. J Cardiovasc Electrophysiol 2003; 14 (Suppl 10): S162-S165. (Pubitemid 37392998)
51. Boriani G, Diemberger I, Biffi M, Domenichini G, Martignani C, Valzania C, Branzi A,. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: Predictors of long-term outcome. Int J Clin Pract 2007; 61: 748-756. (Pubitemid 46587866)
52. Watson JN, Addison PS, Uchaipichat N, Shah AS, Grubb NR,. Wavelet transform analysis predicts outcome of DC cardioversion for atrial fibrillation patients. Comput Biol Med 2007; 37: 517-523. (Pubitemid 46164829)
53. Raitt MH, Volgman AS, Zoble RG, Charbonneau L, Padder FA, O'Hara GE, Kerr D, AFFIRM Investigators. Prediction of the recurrence of atrial fibrillation after cardioversion in the atrial fibrillation follow-up investigation of rhythm management (affirm) study. Am Heart J 2006; 151: 390-396. (Pubitemid 43148983)
54. Lombardi F, Colombo A, Basilico B, Ravaglia R, Garbin M, Vergani D, Battezzati PM, et al,. Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion. J Am Coll Cardiol 2001; 37: 157-162. (Pubitemid 32051732)
55. Fynn SP, Todd DM, Hobbs WJC, Armstrong KL, Fitzpatrick AP, Garratt CJ,. Effect of amiodarone on dispersion of atrial refractoriness and cycle length in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2003; 14: 485-491. (Pubitemid 36583909)
56. Husser D, Stridh M, Cannom DS, Bhandari AK, Girsky MJ, Kang S, Srnmo L, et al., Validation and clinical application of time-frequency analysis of atrial fibrillation electrocardiograms. J Cardiovasc Electrophysiol 2007; 18: 41-46. (Pubitemid 44952742)
57. Husser D, Stridh M, Sörnmo L, Geller C, Klein HU, Olsson SB, Bollmann A,. Time-frequency analysis of the surface electrocardiogram for monitoring antiarrhythmic drug effects in atrial fibrillation. Am J Cardiol 2005; 95: 526-528. (Pubitemid 40247556)
58. Konings KT, Kirchhof CJ, Smeets JR, Wellens HJ, Penn OC, Allessie MA,. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994; 89: 1665-1680. (Pubitemid 24114245)
59. Alcaraz R, Hornero F, Rieta JJ,. Assessment of non-invasive time and frequency atrial fibrillation organization markers with unipolar atrial electrograms. Physiol Meas 2011; 32: 99-114.
60. Wijffels MCEF, Crijns HJGM,. Recent advances in drug therapy for atrial fibrillation. J Cardiovasc Electrophysiol 2003; 14 (Suppl 9): S40-S47. (Pubitemid 37115137)
61. Frick M, Frykman V, Jensen-Urstad M, Ostergren J, Rosenqvist M,. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol 2001; 24: 238-244. (Pubitemid 32187072)
62. Van Gelder IC, Tuinenburg AE, Schoonderwoerd BS, Tieleman RG, Crijns HJ,. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. Am J Cardiol 1999; 84: 147R-151R.
63. Alatawi F, Gurevitz O, White RD, Ammash NM, Malouf JF, Bruce CJ, Moon BS, et al,. Prospective, randomized comparison of two biphasic waveforms for the efficacy and safety of transthoracic biphasic cardioversion of atrial fibrillation. Heart Rhythm 2005; 2 (4): 382-387. (Pubitemid 40443622)
64. Reiffel JA,. Cardioversion for atrial fibrillation: Treatment options and advances. Pacing Clin Electrophysiol 2009; 32: 1073-1084.